# Solstice Oncology, Inc. — Form D

Solstice Oncology, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-09. The offering totals $298.4M, of which $121.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-03-09
- Form: D
- Accession: 0002116600-26-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $298.4M
- Amount sold: $121.3M
- Remaining: $177.1M
- Investors: 8
- Date of first sale: 2026-02-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-575833

## Issuer

- Name: Solstice Oncology, Inc.
- CIK: 0002116600
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2026
- Address: 200 BERKELEY ST., 18TH FLOOR, BOSTON, MA, 02116
- Phone: 617-982-2331

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| JULIE GRANT | Director | WATERTOWN, MA |
| MORGAN HALLER | Director | Boston, MA |
| Andrew Levin | Director | BOSTON, MA |
| Caroline Loew | Director | Boston, MA |
| Emily Minkow | Director | Boston, MA |
| David Feltquate | Executive Officer | Boston, MA |
| Maiken Keson-Brookes | Executive Officer | Boston, MA |
| Caroline Loew | Executive Officer | Boston, MA |
| Caroline Loew | Promoter | Boston, MA |

## More

- [CIK 2116600 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2116600&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002116600-26-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.